It has also been shown that protease-activated receptor 2 (PAR2) deficiency significantly promotes tumor development in the AOM/DSS-induced colitis-associated colon cancer model through accumulation of MDSCs and enhancement of their immunosuppressive activity via STAT3-mediated ROS production (108). Here, STAT3 is linked to colitis.